Negative |
42 (58%) |
Positive |
30 (42%) |
Maternal SARS-CoV-2 spike IgG |
|
Negative |
33 (46%) |
Positive |
39 (54%) |
Maternal SARS-CoV-2 nucleocapsid and spike IgG |
|
Negative |
30 (42%) |
Both positive |
27 (38%) |
One positive |
15 (21%) |
Maternal SARS-CoV-2 spike IgM |
|
Negative |
35 (49%) |
Positive |
36 (51%) |
Neonatal SARS-CoV-2 nucleocapsid IgG |
|
Negative |
42 (58%) |
Positive |
30 (42%) |
Neonatal SARS-CoV-2 spike IgG |
|
Negative |
35 (49%) |
Positive |
37 (51%) |
Neonatal SARS-CoV-2 nucleocapsid and spike IgG |
|
Negative |
32 (44%) |
Both positive |
27 (38%) |
One positive |
13 (18%) |
Neonatal SARS-CoV-2 spike IgM |
|
Negative |
72 (100%) |
Positive |
0 (0%) |
Neonatal PCR for SARS-CoV-2 |
|
Negative |
35 (97%) |
Positive |
1 (3%) |